Sanofi-Aventis and Merck & Co. to Create Global Leader in Animal Health

Sanofi-Aventis (Paris) and Merck & Co., have announced that Sanofi-Aventis has exercised its option to combine its Merial unit with Intervet/Schering-Plough (Boxmeer, the Netherlands), Merck's animal health business, to create a global leader in animal health. The new joint venture will be equally owned by Merck and Sanofi-Aventis. Its formation is subject to execution of final agreements, antitrust review in the U.S., Europe and other countries as well as closing conditions. Completion of the transaction is expected in the next 12 months, the companies say...

This information is only available to Chemical Week subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not an IHS Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive access of the last 2 years of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers